Skip to Main Content

Paper Details

Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer.
Breast Cancer Research
12
2020
Author NameAffiliation
Jason S CarrollCambridge Research Institute, University of Cambridge
  • 1 - 1

Datasets

Release 1.2